Shattuck Labs, Inc. STTK Business Segments — Net Loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Shattuck Labs, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Shattuck Labs, Inc.'s business segments — net loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Shattuck Labs, Inc.'s business segments — net loss?
- Shattuck Labs, Inc. (STTK) reported business segments — net loss of -$14.77M in Q1 2026.
- How has Shattuck Labs, Inc.'s business segments — net loss changed year-over-year?
- Shattuck Labs, Inc.'s business segments — net loss decreased by 7.8% year-over-year, from -$13.7M to -$14.77M.
- What is the long-term trend for Shattuck Labs, Inc.'s business segments — net loss?
- Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s business segments — net loss has grown at a -25.2% compound annual growth rate (CAGR), from -$87.3M to -$48.81M.
- What does business segments — net loss mean?
- This metric measures the bottom-line financial performance of the business segment after accounting for all operating expenses, research costs, and non-operating income. For a clinical-stage biotechnology company, it reflects the net capital burn required to advance the pipeline toward commercialization. It is a primary indicator of the segment's current reliance on external financing or cash reserves.